Novel hybrid molecules based on triazole-quinoline as potential anticancer agents: screening on MCF-7 cell line, docking studies, and pharmacokinetics evaluation

被引:0
|
作者
V. Krishna Chaitanya
P. Jalapathi
M. Ravi Chandar
T. Vishnu
M. Veerabhadraiah
M. Raghavender
机构
[1] Jawaharlal Nehru Technological University Hyderabad,Department of Chemistry, College of Engineering
[2] Osmania University,Department of Chemistry
[3] Mahatma Gandhi Institute of Technology,Department of Chemistry
[4] Chemveda Life Sciences Pvt Ltd,Department of Sciences and Humanities
[5] Matrusri Engineering College,undefined
关键词
Quinoline; 1,2,3-Triazole; MCF-7; Molecular docking; PyRx; Pharmacokinetics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:995 / 1006
页数:11
相关论文
共 39 条
  • [31] Anticancer potential of novel 5-Fluorouracil co-crystals against MCF7 breast and SW480 colon cancer cell lines along with docking studies
    Jubeen, Farhat
    Ijaz, Sana
    Jabeen, Ishrat
    Aftab, Usman
    Mehdi, Wajeeha
    Altaf, Awais
    Alissa, Siham A.
    Al-Ghulikah, Hanan A.
    Ezzine, Safa
    Bejaoui, Imen
    Iqbal, Munawar
    ARABIAN JOURNAL OF CHEMISTRY, 2022, 15 (12)
  • [32] Design, Synthesis, and Screening of 5-Aryl-3-(2-(pyrrolyl)thiophenyl)-1,2,4-oxadiazoles as Potential Antitumor Molecules on Breast Cancer MCF-7 Cell Line
    Abd El Hameid, Mohammed K.
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2018, 66 (12) : 1181 - 1195
  • [33] Redox Mediated Synthesis of Ag-CuO Hybrid Nanoparticles - DNA/BSA Binding Studies and in vitro Evaluation of Anti-cancer Activity on MCF-7 Cancer Cell Line
    Joel, C.
    Jebakumar, D. S. Ivan
    Bennie, R. Biju
    Stuart, J. Gershom
    Raj, A. Nirmal Paul
    David, S. Theodore
    APPLIED ORGANOMETALLIC CHEMISTRY, 2020, 34 (05)
  • [34] Evaluation of Cell Death Potential of Lepidium sativum Seed Extracts in MCF-7 Cells and Molecular Docking-based Correlation of Identified Bioactive Components with Human Caspase-6 Protein
    Rajasekaran, R.
    Suresh, P. K.
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2022, 56 (01) : 166 - 174
  • [35] Bio-Oriented Synthesis and Molecular Docking Studies of 1,2,4-Triazole Based Derivatives as Potential Anti-Cancer Agents against HepG2 Cell Line
    Akhter, Naheed
    Batool, Sidra
    Khan, Samreen Gul
    Rasool, Nasir
    Anjum, Fozia
    Rasul, Azhar
    Adem, Sevki
    Mahmood, Sadaf
    Rehman, Aziz Ur
    Nisa, Mehr Un
    Razzaq, Zainib
    Christensen, Jorn B.
    Abourehab, Mohammed A. S.
    Shah, Syed Adnan Ali
    Imran, Syahrul
    PHARMACEUTICALS, 2023, 16 (02)
  • [36] Synthesis and anticancer evaluation of novel triazole linked N-(pyrimidin-2-yl)benzo[d]thiazol-2-amine derivatives as inhibitors of cell survival proteins and inducers of apoptosis in MCF-7 breast cancer cells
    Kumbhare, Ravindra M.
    Dadmal, Tulshiram L.
    Ramaiah, M. Janaki
    Kishore, K. S. V.
    Valli, S. N. C. V. L. Pushpa
    Tiwari, Sudheer Kumar
    Appalanaidu, K.
    Rao, Y. Khageswar
    Bhadra, Manika Pal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (03) : 654 - 658
  • [37] Design and Synthesis of Novel Pyridine-Based Compounds as Potential PIM-1 Kinase Inhibitors, Apoptosis, and Autophagy Inducers Targeting MCF-7 Cell Lines: In Vitro and In Vivo Studies
    Shaban, Shrouk M.
    Eltamany, Elsayed H.
    Boraei, Ahmed T. A.
    Nafie, Mohamed S.
    Gad, Emad M.
    ACS OMEGA, 2023, 8 (49): : 46922 - 46933
  • [38] Evaluation of antitumor potential of synthesized novel 2-substituted 4-anilinoquinazolines as quinazoline-pyrrole hybrids in MCF-7 human breast cancer cell line and A-549 human lung adenocarcinoma cell lines
    Raju Bathula
    Presenjit Mondal
    Ramakrishna Raparla
    Shobha Rani Satla
    Future Journal of Pharmaceutical Sciences, 6
  • [39] Evaluation of antitumor potential of synthesized novel 2-substituted 4-anilinoquinazolines as quinazoline-pyrrole hybrids in MCF-7 human breast cancer cell line and A-549 human lung adenocarcinoma cell lines
    Bathula, Raju
    Mondal, Presenjit
    Raparla, Ramakrishna
    Satla, Shobha Rani
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)